the effect of IRONPLUS treatment of iron deficiency anemia
Not Applicable
- Conditions
- IRON DEFICIENCY ANEMIA.Iron deficiency anaemia
- Registration Number
- IRCT201506211165N6
- Lead Sponsor
- IAC Pharmaceutical Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Obtaining the informed consent of the patient?Group of iron deficiency anemia
Exclusion criteria:Failure to complete the course of treatment or use instructions
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FERRITIN. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;TIBC. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;TRANSFERIN. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;SERUM IRON. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;RDW. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;HCT HB. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;MCV MCH. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.;PROTOPURPHIRIN. Timepoint: BEFORE AND AFTER OF DRUG. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method SIDE EFFECTS OF DRUG. Timepoint: AFTER Prescription OF DRUG. Method of measurement: Questionnaire.